» Articles » PMID: 32010223

Redo Endoscopic Sleeve Gastroplasty: Technical Aspects and Short-term Outcomes

Overview
Publisher Sage Publications
Specialty Gastroenterology
Date 2020 Feb 4
PMID 32010223
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endoscopic sleeve gastroplasty (ESG) is a restrictive endoscopic bariatric procedure providing promising results. In this short case series, we analyze the technical aspects and short-term outcomes of the redo ESG.

Methods: A retrospective analysis was done on a prospective database of all patients that were selected by a multidisciplinary team that underwent ESG between March 2017 and May 2019. Patients that underwent a redo ESG because of a progressive loss of satiety, weight regain, or insufficient weight loss due to high baseline body mass index were included. Percentage of excess weight loss (%EWL), percentage of total body weight loss (%TBWL), and the Bariatric Analysis and Reporting Outcome System (BAROS) questionnaire were evaluated during follow-up.

Results: A total of 120 ESG procedures were performed with mean %EWL of 44.4% (± 19.5), mean %TBWL of 18.3% (± 6.7), and mean BAROS of 4.5 (± 1.7) at 12 months. Of those, four patients that underwent a redo ESG were identified. A total of three of them had a redo ESG after 12 months from the first ESG, whereas one of them had a redo ESG after 7 months. During the second procedure, old threads were removed with scissors and new stitches were positioned following a triangular pattern and avoiding overlap with the previous stitches. No adverse events were reported during the redo ESG. Six month follow-up was available for three patients, mean %EWL and %TBWL were 44.2% and 20.4%, respectively; BAROS questionnaire mean score was 6.3. One patient had only 1 month follow-up with a mean %EWL and %TBWL of 33.3% and 12.2%, respectively; BAROS questionnaire reported score was 6. All included patients reported excellent satiety feeling after redo ESG.

Conclusions: The redo ESG short-term outcomes are completely satisfying in terms of safety and efficacy. The need to perform a redo ESG should not be considered as a failure of the previous procedure, but it can be considered as a second step of the endoscopic treatment strategy.

Citing Articles

Endoscopic Sleeve Gastroplasty (ESG) Versus Laparoscopic Sleeve Gastroplasty (LSG): A Comparative Review.

Nduma B, Mofor K, Tatang J, Amougou L, Nkeonye S, Chineme P Cureus. 2023; 15(7):e41466.

PMID: 37426405 PMC: 10325692. DOI: 10.7759/cureus.41466.


Per-Oral Plication of (Neo)Esophagus: Technical Feasibility and Early Outcomes.

Hedberg H, Attaar M, McCormack M, Ujiki M J Gastrointest Surg. 2023; 27(8):1531-1538.

PMID: 37052876 PMC: 10100616. DOI: 10.1007/s11605-021-05205-9.


Personalized Approach for Obese Patients Undergoing Endoscopic Sleeve Gastroplasty.

Matteo M, DOria M, Bove V, Carlino G, Pontecorvi V, Raffaelli M J Pers Med. 2021; 11(12).

PMID: 34945770 PMC: 8704248. DOI: 10.3390/jpm11121298.


Endoscopic sleeve gastroplasty is feasible after failed modified primary obesity surgery endoluminal procedure.

Bove V, Pontecorvi V, Matteo M, Costamagna G, Boskoski I VideoGIE. 2021; 6(9):410-412.

PMID: 34527839 PMC: 8431246. DOI: 10.1016/j.vgie.2021.05.019.


Endobariatric procedures for obesity: clinical indications and available options.

Goyal H, Kopel J, Perisetti A, Mann R, Ali A, Tharian B Ther Adv Gastrointest Endosc. 2021; 14:2631774520984627.

PMID: 33629061 PMC: 7841245. DOI: 10.1177/2631774520984627.


References
1.
Abu Dayyeh B, Acosta A, Camilleri M, Mundi M, Rajan E, Topazian M . Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals. Clin Gastroenterol Hepatol. 2016; 15(1):37-43.e1. DOI: 10.1016/j.cgh.2015.12.030. View

2.
Lopez-Nava G, Galvao M, Bautista-Castano I, Fernandez-Corbelle J, Trell M, Lopez N . ENDOSCOPIC SLEEVE GASTROPLASTY FOR OBESITY TREATMENT: TWO YEARS OF EXPERIENCE. Arq Bras Cir Dig. 2017; 30(1):18-20. PMC: 5424680. DOI: 10.1590/0102-6720201700010006. View

3.
Lopez-Nava Breviere G, Bautista-Castano I, Fernandez-Corbelle J, Trell M . Endoscopic sleeve gastroplasty (the Apollo method): a new approach to obesity management. Rev Esp Enferm Dig. 2016; 108(4):201-6. DOI: 10.17235/reed.2016.3988/2015. View

4.
Alqahtani A, Al-Darwish A, Mahmoud A, Alqahtani Y, Elahmedi M . Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2018; 89(6):1132-1138. DOI: 10.1016/j.gie.2018.12.012. View

5.
Apovian C . Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016; 22(7 Suppl):s176-85. View